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Macrophages regulate cell fate decisions during microbial challenges by carefully titrating signaling events activated by innate
receptors such as dectin-1 or Toll-like receptors (TLRs). Here, we demonstrate that dectin-1 activation robustly dampens TLR-
induced proinflammatory signature in macrophages. Dectin-1 induced the stabilization of -catenin via spleen tyrosine kinase
(Syk)-reactive oxygen species (ROS) signals, contributing to the expression ofWNT5A. Subsequently, WNT5A-responsive pro-
tein inhibitors of activated STAT (PIAS-1) and suppressor of cytokine signaling 1 (SOCS-1) mediate the downregulation of
IRAK-1, IRAK-4, andMyD88, resulting in decreased expression of interleukin 12 (IL-12), IL-1, and tumor necrosis factor alpha
(TNF-). In vivo activation of dectin-1 with pathogenic fungi or ligand resulted in an increased bacterial burden ofMycobacte-
ria,Klebsiella, Staphylococcus, or Escherichia, with a concomitant decrease in TLR-triggered proinflammatory cytokines. All to-
gether, our study establishes a new role for dectin-1-responsive inhibitory mechanisms employed by virulent fungi to limit the
proinflammatory environment of the host.
Activation of host pattern recognition receptors (PRRs) uponengagement by invading microbe or microbe-associated mo-
lecular patterns to elicit protective immune responses is one of the
most well-studied physiological processes (1–4). However, damp-
ening of the protective innate immune cell functions during mul-
tiple infections upon engagement of many PRRs constituting dif-
ferent families has not been explored. Dectin-1, a C-type lectin
receptor (CLR) expressed on the surface of antigen-presenting
cells, like macrophages and dendritic cells, are sensors of invading
fungi and elicit predominantly Th17-mediated immune re-
sponses. For example, Candida albicans, a major opportunistic
pathogen, is the cause of severe candidiasis affecting individuals
under immunocompromised conditions (5, 6). In addition to
this, several other fungi are shown to cause many dreadful diseases
in immune-deficient individuals (7, 8). Significantly, in spite of
driving the T cell responses toward the Th17 inflammatory phe-
notype through the dectin-1 receptor, the protection against se-
vere candidiasis is not completely attained (9). Of note, recent
reports have clearly implicated that engagement/activation of dec-
tin-1 receptor by fungi or fungal counterparts intercepts the pro-
tective functional role of other PRRs, majorly Toll-like receptors
(TLRs). Activation of dectin-1 by C. albicans has been shown to
induce interleukin 10 (IL-10), which has an inhibitory effect over
TLR by targeting MyD88 (10, 11). Similar studies have also shown
that dampening of TLR-triggered protective immune responses is
mediated by dectin-1-induced expression of suppressor of cyto-
kine signaling 1 (SOCS-1) (12).
The dectin-1 signaling network is comprised of an immediate
intracellular signaling kinase, spleen tyrosine kinase (Syk). Acti-
vation of Syk elicits the robust production of reactive oxygen spe-
cies (ROS) and subsequently induces NF-B-driven gene expres-
sion (13). However, the signaling intermediates bridging the
potent secondary messenger-mediated activation and subsequent
NF-B-induced gene expression are not established.
Here, we demonstrate that activation of dectin-1 receptor by
fungi or by its cognate ligand, curdlan, leads to the induced ex-
pression of protein inhibitors of activated STAT (PIAS-1) and
SOCS-1. PIAS-1 and SOCS-1 are known to be the potential post-
translation protein modifiers that regulate the function of several
cytoplasmic as well as nuclear proteins. PIAS molecules are shown
to alter the protein stability and localization of several signaling
molecules and epigenetic regulators. On the other hand, SOCS
molecules with E3 ubiquitin ligase activity are shown to mediate
proteasomal degradation of vital signaling adaptors to downregu-
late the receptor signal strength (14, 15). Elevated levels of ROS
due to dectin-1 signaling stabilized-catenin and collectively con-
tributed to the expression of WNT5A. Subsequently, secreted
WNT5A activates the calcium-activated calmodulin kinase
(Ca2/CAMKII) pathway to induced PIAS-1 and SOCS-1 expres-
sion through the TAK1–NF-B axis. Importantly, we demon-
strate that overexpression of PIAS-1 and SOCS-1 in macrophages
leads to reduced protein levels of pivotal TLR adaptors, such as
IRAK-1, IRAK-4, and MyD88. The dectin-1-dependent increased
burden of the tested bacteria, in vivo as well as in vitro, in the
presence of curdlan or C. albicans infection and lowered levels of
tumor necrosis factor alpha (TNF-), IL-12, and IL-1 cytokines
upon infection with fungi further substantiated our findings. In
summary, the study reinforces the existence of a counteracting
effect among two PRR families during multiple infections. We
propose that the invading pathogens exploit such mechanisms to
evade protective responses and also drive the less pathogenic
(commensal) bacteria to become opportunistic pathogens.
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MATERIALS AND METHODS
Mice. Thioglycolate-elicited peritoneal macrophages were isolated from
wild-type (WT) (C3H/HeJ or C57BL/6J) mice or TLR2/ or NCF1/
mice in a C57BL/6J background that were maintained at the Central An-
imal Facility, Indian Institute of Science. The RAW 264.7 mouse macro-
phage cell line (obtained from National Centre for Cell Sciences, Pune,
India) was cultured in Dulbecco’s modified Eagle’s medium (DMEM)
(Gibco-Invitrogen, USA) supplemented with 10% heat-inactivated fetal
bovine serum (FBS; Sigma-Aldrich, USA). The experiments with mouse
macrophages were carried out after the approval from the Institutional
Ethics Committee for animal experimentation as well as from the Institu-
tional Biosafety Committee.
Reagents and antibodies. Curdlan (100 g/ml), PAM3CSK4 (1 g/
ml), R848 (1 g/ml), flagellin (0.1 g/ml), CpG DNA (10 g/ml), lipo-
polysaccharide (LPS) (100 ng/ml), and laminarin (100 g/ml) were ob-
tained from Invivogen, USA. Anti-Ser9 phospho-glycogen synthase
kinase 3 (pGSK-3), anti-Ser-33/37/Thr41 phospho--catenin, anti--
catenin, anti-Tyr402 phospho-PYK2, anti-Tyr323 phospho-Syk, anti-
Tyr231 phospho-CAMKII, anti-Ser412 phospho-TAK1, anti-TAK1,
anti-NF-B p65, anti-WNT5A, anti-PIAS-1, anti-SOCS-1, anti-IRAK-1,
anti-IRAK-4, anti-IRAK-M, and anti-MyD88 were purchased from Cell
Signaling Technology (USA). Anti-rabbit horseradish peroxidase (HRP)-
conjugated antibody, anti-mouse HRP-conjugated antibody, and anti-
rabbit antibody–Alexa Fluor 647 were obtained from Jackson Immu-
noResearch (USA). Anti--actin antibody conjugated to HRP was
purchased from Sigma-Aldrich. Anti-mouse PCNA was purchased from
Calbiochem (Germany). Anti-Myc and anti-Flag antibodies were ob-
tained from Santa Cruz Biotechnology, Inc. (USA). 4=,6-Diamidino-2-
phenylindole dihydrochloride (DAPI) was from Sigma-Aldrich.
Fungal cultures. C. albicans (MTCC 4748), Aspergillus flavus (MTCC
9064), and Aspergillus fumigatus (MTCC 1811) were obtained from Mi-
crobial Type Culture Collection, IMTECH, Chandigarh, India.C. albicans
was grown on Sabouraud-dextrose agar (SDA) plates, and colonies were
picked and subjected to liquid cultures. Log-phase cultures were har-
vested and enumerated for CFU. A. flavus and A. fumigatus were plated
and subcultured on SDA plates and incubated for 4 days at 30°C. Conidia
were harvested by gently scraping the surface of 4-day-old culture with an
inoculation needle and collected in vials containing 5 ml phosphate-buff-
ered saline (PBS), pH 7, and 0.01% (vol/vol) sterile polyoxyethylene sor-
bitan monooleate (Tween 20; Merck) solution. The concentration of
conidia in different suspensions was determined by using a Neubauer
hemocytometer. Serial dilutions were prepared in sterile PBS containing
Tween 20. The viability of conidia was determined by a plate count tech-
nique on SDA plates.
Transient-transfection studies. Murine RAW 264.7 macrophages
were transiently transfected with respective target-specific small interfer-
ing RNA (siRNA) or with control nontargeting siRNA using low-molec-
ular-weight polyethylenimine (Sigma-Aldrich). Similarly, transient trans-
fection with various dominant negative or overexpression (OE)
constructs was carried out along with vector controls. Mouse Wnt5a
siRNA, Tak1 siRNA,-catenin siRNA, and Dectin-1 siRNA were obtained
from Dharmacon (USA) as siGENOME SMARTpool reagents, which
contain a pool of four different double-stranded RNA oligonucleotides.
Transient-transfection efficiency was found to be more than 50%, as es-
timated by counting the number of siGLO lamin A/C-positive cells in a
microscopic field using fluorescence microscope. In all the cases, 48 h
posttransfection, the cells were treated or infected as indicated and pro-
cessed for analysis.
Treatment with pharmacological reagents. In the experiments in-
volving pharmacological reagents, cells were treated with respective in-
hibitors for 1 h prior to treatment with the ligand at the following con-
centrations: MG-132, 10 M; Syk inhibitor, 10 M; DPI, 10 M;
-catenin inhibitor, 15 M; LiCl, 5 mM; IWP-II, 5 mM; PTX, 200 ng;
BAPTA-AM, 10M; KN-93, 10M; AG-17, 15M; and BAY 11-7082, 10
M. All the pharmacological inhibitors were purchased from Calbi-
ochem. Dimethyl sulfoxide (DMSO) at 0.1% concentration was used as a
vehicle control. A tested concentration of each pharmacological reagent
was identified by a careful titration experiment assessing the viability of
macrophages using an MTT [3-(4,5-dimethylthiazol-2yl)-2,5-diphe-
nyltetrazolium bromide] assay prior to utilization in the experimental
studies.
Immunofluorescence. RAW 264.7 macrophages were seeded onto
coverslips and treated as indicated. The cells were fixed with 3.7% para-
formaldehyde for 15 min at room temperature. After blocking, cells were
incubated with primary antibodies in saponin-containing diluent over-
night at 4°C. Secondary antibody incubation was in the dark for 1 h at
room temperature. Nuclear staining was performed with DAPI for 2 min.
Coverslips with cells were then mounted on a slide with glycerol. Confocal
images were taken on a Zeiss LSM 710 Meta confocal laser scanning mi-
croscope (Carl Zeiss AG, Germany) using a Plan-Apochromat 63mag-
nification/1.4-numerical-aperture oil differential inference contrast
(DIC) objective (Carl Zeiss AG), and images were analyzed using ZEN
2009 software.
Immunopulldown. Immunopulldown assays were carried out using a
protocol with certain modifications provided by Millipore, USA. In brief,
macrophages were gently suspended and lysed in ice-cold RIPA buffer.
Obtained cell lysates were incubated with anti-Flag or anti-Myc antibod-
ies (in respective experimental setup) or with rabbit preimmune sera at
4°C for 2 h in shaking conditions. The immune complexes were captured
upon addition of protein A (Bangalore Genei, India)-agarose beads at 4°C
for 2 h. The beads were separated, washed, and boiled in 5 Laemmli
buffer for 10 min. These samples were analyzed for respective target mol-
ecules upon separation by SDS-PAGE followed by an immunoblotting
technique.
Intracellular ROS detection. A total of 1  106 peritoneal macro-
phages or RAW 264.7 macrophages transfected with respective constructs
were treated with curdlan (100g/ml) for various time points. After treat-
ment, cells were washed with fresh medium and then incubated with fresh
DMEM containing 10 m 2=,7=-dichlorofluorescein diacetate (DCFDA)
to the final concentration for 30 min, and then cells were washed with
PBS to remove excess DCFDA. The cells were analyzed for fluorescence
emitted due to ROS from DCFDA by using fluorescence spectropho-
tometer with an excitation wavelength of 495 nm and emission wave-
length of 529 nm.
RNA isolation and quantitative real-time RT-PCR. Total RNA from
infected macrophages was isolated by the TRIzol method (Sigma-Aldrich,
USA) as per the manufacturer’s protocol and treated with RNase-free
DNase (Promega, USA). The cDNA synthesis kit (Bioline, United King-
dom) was used for reverse transcription (RT) according to the manufac-
turer’s protocol. A real-time PCR amplification (Applied Biosystems,
USA) using SYBR green PCR mix (Kappa Biosystems, USA) was per-
formed for quantification of target gene expression with the following
conditions: 45 cycles of 94°C for 20 s, 60°C for 30 s, and 72°C for 30 s. All
reactions were repeated at least three times independently to ensure the
reproducibility of the results. Amplification of the Gapdh housekeeping
gene was used as an internal control. Primer sequences used in the study
are as follows: Gapdh forward, 5=-GAGCCAAACGGGTCATCATCT-3=;
Gapdh reverse, 5=-GAGGGGCCATCCACAGTCTT-3=; Wnt5a forward,
5=-TGCGGAGACAACATCGACTAT-3=; Wnt5a reverse, 5=-TCCATGAC
ACTTACAGGCTACA-3=; Pias-1 forward, 5=-ACGCAAACACGAACTT
CTTACA-3=; Pias-1 reverse, 5=-TCCGCAGGCGTCATAATTTTC-3=;
Socs-1 forward, 5=-CTGCGGCTTCTATTGGGGAC-3=; Socs-1 reverse,
5=-AAAAGGCAGTCGAAGGTCTCG-3=; Dectin-1 forward, 5=-GACTTC
AGCACTCAAGACATCC-3=; Dectin-1 reverse, 5=-TTGTGTCGCCAAA
ATGCTAGG-3=.
Nuclear fractionation. Cells were treated as indicated, harvested by
centrifugation, and gently resuspended in ice-cold buffer A (10 mM
HEPES [pH 7.9], 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM
dithiothreitol [DTT], and 0.5 mM phenylmethylsulfonyl fluoride
[PMSF]). After incubation on ice for 15 min, cell membranes were dis-
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rupted with 10% NP-40, and the nuclear pellets were recovered by cen-
trifugation at 4,000 rpm for 15 min at 4°C. The supernatants from this step
were used as cytosolic extracts. Nuclear pellets were lysed with ice-cold
buffer C (20 mM HEPES [pH 7.9], 0.4 M NaCl, 1 mM EDTA, 1 mM
EGTA, 1 mM DTT, and 1 mM PMSF), and nuclear extracts were collected
after centrifugation at 13,000 rpm for 20 min at 4°C.
In vivo bacterial challenge and bacterial viability assays.Each exper-
imental set (in vivo) consisted of 4 mice. Each mouse was intravenously or
intraperitoneally injected with 500g of curdlan, and after 6 h, mice were
intravenously or intraperitoneally challenged with respective bacteria
(1 106) obtained from MTCC. After 48 to 72 h of challenge, mice were
sacrificed. In the case of intravenous challenge, bacterial CFU were enu-
merated from spleen and lymph node, and in the case of intraperitoneal
challenge, peritoneal exudates were isolated and bacterial CFU were enu-
merated. Similarly, bacterial CFU were enumerated after peritoneal mac-
rophages were infected (0.5  106/ml) in vitro or nontargeting (NT)/
Dectin-1 siRNA-transfected RAW 264.7 macrophages were infected
(0.3  106/ml) with respective bacteria (1:10 multiplicity of infection
[MOI]) for 18 h in the presence or absence of curdlan (100 g/ml) or C.
albicans coinfection.
Immunoblotting. Cells were washed with ice-cold PBS and scraped
off the culture dish and collected by centrifugation. Cell pellets were lysed
in RIPA buffer consisting of 50 mM Tris-HCl (pH 7.4), 1% NP-40, 0.25%
sodium deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1g/ml
of aprotinin, leupeptin, and pepstatin, 1 mM Na3VO4, and 1 mM NaF and
incubated on ice for 30 min. Whole-cell lysate was collected by centrifug-
ing lysed cells at 13,000 rpm for 10 min at 4°C. Protein concentration in
each cell lysate was determined by Bradford’s method of protein detec-
tion. Equal protein amounts from each cell lysate were subjected to SDS-
PAGE and transferred onto polyvinylidene difluoride membranes (Milli-
pore) by using the semidry Western blotting (Bio-Rad, USA) method.
Nonspecific binding was blocked with 5% nonfat dry milk powder in
TBST (20 mM Tris-HCl [pH 7.4], 137 mM NaCl, and 0.1% Tween 20) for
60 min. The blots were incubated overnight at 4°C with primary antibod-
ies diluted in TBST with 5% bovine serum albumin (BSA). After being
washed with TBST, blots were incubated with anti-rabbit or anti-mouse
IgG secondary antibody conjugated to HRP diluted in TBST with 5% BSA
for 2 h. After further washing in TBST, the immunoblots were developed
with the enhanced chemiluminescence detection system (PerkinElmer,
USA) as per the manufacturer’s instruction.
Cytokine detection. Cell-free supernatants were obtained from vari-
ous experimental setups and were analyzed for TNF-, IL-12, and IL-1
by enzyme-linked immunosorbent assay (ELISA) by utilizing kits pro-
cured from BD Biosciences (USA), according to the manufacturer’s pro-
tocol.
Statistical analysis. Levels of significance for comparison among the
samples were determined by Student t test distribution and one-way anal-
ysis of variance (ANOVA). The represented graphical data are expressed
as the means	 standard errors of the means (SEM) of 4 to 5 values from
3 independent experiments unless mentioned otherwise. P values of

0.05 were considered to be significant. Prism 5.0 software (GraphPad
Software, Inc., USA) was used for all the statistical analysis.
RESULTS
Dectin-1 signaling intercepts TLR inflammatory signature. Sev-
eral studies indicated the possible cross-regulation of dectin-1–
TLR pathways (16). However, the mechanistic details of such in-
teractions during multiple infections are scanty. In this regard, we
chose to study the effect of dectin-1 signaling on the TLR path-
ways. Prior activation of dectin-1 receptor in macrophages upon
infection with C. albicans, A. flavus, and A. fumigatus inhibited
TLR (TLR1, -2, -4, -5, -7, -8, -9)-induced expression of inflamma-
tory cytokines, such as TNF-, IL-12, and IL-1 (Fig. 1A to C).
Further, utilization of cognate ligand to the curdlan dectin-1 re-
ceptor also exhibited similar inhibitory effect (Fig. 2A). Lami-
narin, a competitive ligand to dectin-1 receptor with no signaling
FIG 1 Fungus-activated dectin-1 limits TLR-induced cytokines. (A to C) Mouse macrophages from C57BL/6J mice were infected with C. albicans (C. alb), A.
flavus (A. flav), or A. fumigatus (A. fum), respectively, at an MOI of 1:10 for 6 h followed by treatment with TLR ligands for an additional 18 h in the presence or
absence of 100g/ml laminarin (Lam). Lam treatment alone served as a control. Cell-free supernatants were analyzed for TNF-, IL-12, and IL-1 by ELISA. All
data represent the means	 SEM from 3 independent experiments. *, P
 0.05; **, P
 0.005; ***, P
 0.001.
Dectin-1 Downregulates TLR Responses
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attributes, completely blocked the inhibitory potential of dectin-1
over TLR functions (Fig. 1 and Fig. 2A). Importantly, treatment of
macrophages with laminarin alone did not have any effect on cy-
tokine production. These results underscore the role of dectin-1
receptor signaling during fungus-mediated downregulation of
immune responses. Additionally, the inhibitory effect of dectin-1
signaling on the immune protective functions of TLR was directly
correlated with the increased bacterial viability. While treatment
of curdlan prior to infection with Escherichia coli, Mycobacterium
smegmatis, Staphylococcus aureus, or Klebsiella pneumoniae led to
enhanced survival of bacteria in peritoneal macrophages (Fig. 2B)
and nontargeting siRNA-transfected macrophages (Fig. 2C and
D), we found significant decreases in the bacterial CFU inDectin-1
siRNA-transfected macrophages despite the curdlan treatment
(Fig. 2C and D). This suggests that curdlan-dependent enhanced
bacterial survival is specifically dectin-1 mediated. Further estab-
lishing this observation in vivo, the intraperitoneal inoculation of
mice with curdlan prior to the challenge of mice with bacteria via
the same route significantly enhanced the survival of bacteria in
macrophages of the peritoneal exudate (Fig. 2E). Similar results
were obtained when assessed for bacterial CFU in the spleens
(Fig. 2F, left) and lymph nodes (Fig. 2F, right) of mice challenged
with bacteria after treatment with curdlan. RNA interference of
Dectin-1 significantly reduced the ability of C. albicans to protect
the tested bacteria, E. coli, M. smegmatis, S. aureus, or K. pneu-
moniae, from clearance in the macrophages compared to that in
macrophages transfected with nontargeting siRNA (Fig. 2G). To-
gether, these results imply that there exists a counterregulation by
dectin-1 on TLR receptors.
Dectin-1-induced PIAS-1 and SOCS-1 negatively influence
TLR signaling by targeting IRAK-1, IRAK-4, and MyD88. Im-
paired TLR signaling can be attributed to several molecular pro-
cesses, including the downregulation of TLR signaling adaptors,
induction of SOCS, and inhibitory IRAK, such as IRAK-M (17–
19). As shown in Fig. 3A and B, infection of macrophages with C.
albicans, A. flavus, or A. fumigatus abrogated the expression of the
TLR signaling adaptors, IRAK-1, IRAK-4, and MyD88. However,
no change in the expression levels of inhibitory IRAK-M was ob-
served with infection of macrophages with the tested fungi (Fig.
3A). Though the existing literature emphasized the requirement
FIG 2 Interception of protective TLR-induced cytokines by dectin-1 engagement favors bacterial survival. (A) Mouse macrophages from C57BL/6J mice were
treated with dectin-1 ligand, curdlan (100g/ml), for 6 h, followed by treatment with TLR ligands for an additional 18 h in the presence or absence of Lam. Lam
treatment alone served as a control. Cell-free supernatants were analyzed for TNF-, IL-12, and IL-1 by ELISA. (B and C) Mouse peritoneal macrophages (B)
or nontargeting (NT) or Dectin-1 siRNA-transfected RAW 264.7 macrophages (C) were treated with curdlan for 6 h followed by infection with the indicated
bacteria at an MOI of 1:10 for 18 h. Cells were lysed and enumerated for bacterial CFU. (D) Validation of Dectin-1 siRNA action in RAW 264.7 cells. (E)
Intraperitoneal injection of mice with curdlan for 6 h followed by intraperitoneal challenge with the indicated bacteria (1  106 CFU) for 18 h. Peritoneal
macrophages were isolated and enumerated for bacterial CFU. (F) Intravenous infusion of mice with curdlan for 6 h followed by intravenous challenge of mice
with the indicated bacteria (1 106 CFU) for 18 h. Spleen and lymph nodes were isolated and enumerated for bacterial CFU. (G) RAW 264.7 cells transiently
transfected with NT orDectin-1 siRNA were infected withC. albicans for 6 h prior to 18 h of infection with the indicated bacteria. Cells were lysed and enumerated
for bacterial CFU. All data represent the means	 SEM from 3 independent experiments. *, P
 0.05; **, P
 0.005; ***, P
 0.001; ns, not significant.
Trinath et al.
4304 mcb.asm.org Molecular and Cellular Biology
 o
n
 N
ovem
ber 9, 2016 by guest
http://m
cb.asm
.org/
D
ow
nloaded from
 
of TLR2 for effector functions of dectin-1 (20, 21), surprisingly,
we observed that infection of macrophages from TLR2-null mice
with the tested fungi or curdlan (Fig. 3C) followed a similar trend.
This suggests that dectin-1 can function independent of TLR2.
However, siRNA-mediated knockdown of dectin-1 compromised
the ability of these fungi (Fig. 3D) or curdlan (Fig. 3E to G) to
downregulate IRAK-1, IRAK-4, and MyD88.
Previous reports have suggested the crucial role for posttrans-
lational modifications of IRAK-1 (22), IRAK-4 (23), and MyD88
(24) to dampen TLR responses. Additionally, SOCS-1 was also
found to modulate TLR responses (25). We thus assessed the role
for posttranslational modifications by PIAS-1 and SOCS-1 in tar-
geting TLR signaling adaptors like IRAK-1, IRAK-4, and MyD88.
Interestingly, engagement of dectin-1 with respective fungi (Fig.
3A and B) or curdlan (Fig. 3C) induced the expression of PIAS-1
and SOCS-1 independent of TLR2, further potentiating the inde-
pendent role for dectin-1. We also observed the essential role of
dectin-1 receptor in fungus (Fig. 3D)- or curdlan (Fig. 3E to G)-
induced expression of PIAS-1 and SOCS-1. Concurrently, while
expression of IRAK-1, IRAK-4, and MyD88 was reduced after
treatment with curdlan with dose (Fig. 4A) and time (Fig. 4B),
PIAS-1 and SOCS-1 levels were found to be upregulated (Fig. 4C
and D). Next, to establish the role of dectin-1-responsive PIAS-1
and SOCS-1 in targeting TLR2 adaptor molecules, immune pull-
down assays were performed. Flag/Myc-immunoprecipitates
from cells transfected with PIAS-1-Flag or SOCS-1-Myc OE con-
structs were probed for IRAK-1, IRAK-4, and MyD88. As illus-
trated in Fig. 4E to J, while SOCS-1 targeted IRAK-1, IRAK-4, and
MyD88 for proteasomal degradation, PIAS-1 was found to target
IRAK-1 and MyD88.
The Syk–ROS–-catenin axismediates dectin-1-induced ex-
pression of PIAS-1 and SOCS-1.The signaling cohorts associated
with the dectin-1 receptor axis are Syk, ROS, and NF-B, the tran-
scription factor-regulating gene expression (26–28). ROS, being
one of the potent second messengers, is shown to regulate signal-
ing pathways either by stabilization of intermediates or destabili-
zation of negative regulators of signaling pathways. One such
pathway shown to be modulated by the redox state of the cell is the
WNT signaling pathway (29). Additionally, emerging reports
have clearly emphasized the decisive role for the WNT pathway in
FIG 3 Dectin-1 signaling downregulates the expression of IRAK-1, IRAK-4, and MyD88 and upregulates PIAS-1 and SOCS-1. (A) Immunoblot analysis of
IRAK-1, IRAK-4, MyD88, PIAS-1, and SOCS-1 in macrophages from C57BL/6J WT and TLR2/ mice infected with respective fungi for 12 h. (B) RAW 264.7
macrophages were infected with the indicated fungi for 12 h. Representative immunofluorescence images (left) and MFI (right) for IRAK-1, IRAK-4, MyD88,
PIAS-1, and SOCS-1 are shown. (C) Peritoneal macrophages from C57BL/6J WT or TLR2/ mice were treated with curdlan for 12 h. Whole-cell lysates were
analyzed for the indicated genes by immunoblotting. (D) Murine RAW 264.7 macrophages were transiently transfected with Dectin-1 siRNA followed by
infection with respective fungi at an MOI of 1:10. Whole-cell lysates were analyzed for IRAK-1, IRAK-4, MyD88, PIAS-1, and SOCS-1 by immunoblotting.
Immunofluorescence (E) and immunoblotting (F) analysis of IRAK-1, IRAK-4, MyD88, PIAS-1, and SOCS-1 in RAW 264.7 macrophages (E) or peritoneal
macrophages from C3H/HeJ mice (F) transiently transfected with Dectin-1 siRNA followed by treatment with curdlan for 12 h. (G) Validation of Dectin-1 siRNA
action in peritoneal macrophages. All blots are representative of 3 independent experiments, and all data represent the means 	 SEM from 3 independent
experiments. *, P
 0.05; **, P
 0.005; ***, P
 0.001; ns, not significant; Med, medium; WT, wild type; NT, nontargeting. Bar, 5 m.
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immune cell fate decisions during pathogenic infections (30, 31).
In the off state, phosphorylation of -catenin by GSK-3 leads to
its proteosomal degradation and suppresses the WNT pathway
(32). Disheveled (Dvl1), an upstream negative regulator, modu-
lates catalytic activity of GSK-3, which itself is under the control
of a cytosolic redox sensor, nucleoredoxin (NRX). NRX, in a re-
duced state, holds the activity of Dvl1, as a result of which GSK-3
is functionally active and subjects -catenin to proteasomal deg-
radation. An increase in ROS oxidizes NRX, by which Dvl1 is
relieved, and blocks the activity of GSK-3 and stabilizes
-catenin independent of the WNT ligand. We investigated the
existence of such mechanisms in dectin-1-induced expression of
PIAS-1 and SOCS-1. Activation of dectin-1 receptor with curdlan
led to an increase in phosphorylation of Syk and subsequently
induced production of ROS (Fig. 5A to D) and led to the expres-
sion of PIAS-1 and SOCS-1 (Fig. 5E). Further, utilization of mac-
rophages from TLR2-null mice implicated the TLR2-independent
role for dectin-1 in executing its functions (Fig. 5F). The role of
ROS in the dectin-1-mediated signaling pathway was further po-
tentiated by utilizing macrophages from NCF1/ (ROS/)
mice. We demonstrated that the dectin-1-induced expression of
PIAS-1 and SOCS-1 is significantly reduced in macrophages defi-
cient in ROS production in vitro (Fig. 5G). Similarly, intravenous
inoculation of mice with curdlan and further analysis of PIAS-1
and SOCS-1 in spleen and lymph node implicated the role for
ROS in dectin-1-responsive PIAS-1 and SOCS-1 expression (Fig.
5H). Pharmacological intervention of dectin-1 signaling by the
Syk inhibitor or inhibition of ROS production by DPI showed the
pronounced effect on stabilization of -catenin (Fig. 6A). Curd-
lan-induced expression of PIAS-1 and SOCS-1 was brought down
by the overexpression of wild-type NRX, which resulted in in-
creased sequestration of Dvl1 and subsequent abrogation of WNT
signaling (Fig. 6B). In such a scenario, curdlan-induced ROS was
insufficient to rescue PIAS-1 and SOCS-1 levels. The overex-
pressed mutant form of NRX was unable to induce PIAS-1 and
SOCS-1. Also, overexpressed Dvl1 bypassed the requirement of
both NRX and ROS, constitutively activating WNT signaling and
in turn inducing PIAS-1 and SOCS-1 (Fig. 6B). We further poten-
tiated the contribution of ROS in stabilization of -catenin and
induced expression of PIAS-1 and SOCS-1 by immunopulldown
assay and observed that intervention of ROS induced by curdlan
prevents Dvl1-NRX interaction, subsequently leading to the sta-
FIG 4 Dectin-1 signaling targets IRAK-1, IRAK-4, and MyD88 by inducing PIAS-1 and SOCS-1. (A and B) Immunoblot analyses of IRAK-1, IRAK-4, and
MyD88 in cell lysates of macrophages treated with different concentrations of curdlan for 12 h (A) or with 100g/ml curdlan for the indicated time intervals (B).
(C and D) Peritoneal macrophages were treated with different concentrations of curdlan (C) or with 100g/ml curdlan for various time intervals (D). Whole-cell
lysates were analyzed for PIAS-1 and SOCS-1 by immunoblotting. (E and F) Transient transfection of RAW 264.7 macrophages with PIAS-1 OE or SOCS-1 OE
construct, respectively, in the presence or absence of MG-132 followed by immunoblotting analysis of IRAK-1, IRAK-4, and MyD88. (G and H) Immunopull-
down (IP) assay with anti-Flag (G) or anti-Myc (H) antibodies in cell lysates of RAW 264.7 macrophages transfected with PIAS-1 OE (G) or SOCS-1 OE (H),
followed by immunoblotting analysis of IRAK-1, IRAK-4, and MyD88. (I and J) Validation of PIAS-1 OE (I) and SOCS-1 OE (J) constructs using immuno-
blotting with respective antibodies. All blots are representative of 3 independent experiments. Med, medium; WT, wild type; OE, overexpression construct; IB,
immunoblot; NT, nontargeting.
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bilization of -catenin. Correspondingly, inhibition of ROS by
SyK inhibitor, DPI, or a dectin-1 mutant construct promoted
Dvl1-NRX interaction, resulting in -catenin degradation (Fig.
6C). Blocking of GSK-3 by LiCl (Fig. 6D) or overexpression of
-catenin (Fig. 6E and F) or transient knockdown of -catenin
(Fig. 6G and H) implicated a role for -catenin in dectin-1 signal-
ing axis-mediated expression of PIAS-1 and SOCS-1. Supporting
these observations, unlike the three bacteria, infection of macro-
phages with C. albicans, A. flavus, and A. fumigatus induced robust
activation of WNT signaling and increased expression of PIAS-1
and SOCS-1 (Fig. 6I). These results are in accordance with our
previous data, which showed that E. coli, M. smegmatis, and S.
aureusdo not activate WNT signaling in the infected macrophages
(31). Further coinfection of C. albicans with the tested bacteria did
not alter the ability of the fungi to induce the activation of the
WNT pathway or expression of PIAS-1 and SOCS-1 (Fig. 6J).
Dectin-1-induced expressionofPIAS-1 andSOCS-1 requires
WNT5A-Ca2/CAMKII signaling. A screen for WNT ligands
identified WNT5A as a significant dectin-1-responsive ligand that
arbitrates the WNT signaling pathway (Fig. 7A and B). However,
as shown earlier, stabilization of-catenin led to the expression of
PIAS-1 and SOCS-1 (Fig. 6G). Intriguingly, we observed the in-
duction of PIAS-1 and SOCS-1 in WNT5A-transfected RAW
264.7 macrophages even in the presence of -catenin inhibitor
(Fig. 7C). This suggests that PIAS-1 and SOCS-1 are not the direct
targets of -catenin-mediated transcription but are WNT5A de-
pendent. Concordant with our previous observation, we found
that dectin-1 receptor was essential for curdlan-induced expres-
sion of WNT5A (Fig. 7D and E). Further, there was a significant
reduction in the curdlan-induced expression of WNT5A in mice
deficient for ROS production (Fig. 7F and G). Additionally, stabi-
lization of -catenin led to induced expression of WNT5A (Fig.
7H to K). The pivotal role of WNT5A in dectin-1-induced expres-
sion of PIAS-1 and SOCS-1 was validated by overexpression or
transient knockdown of WNT5A. We demonstrated that overex-
pression of WNT5A led to augmented expression of curdlan-in-
duced PIAS-1 and SOCS-1 (Fig. 7L and M). Further, knockdown
of WNT5A by siRNA reduced the expression of PIAS-1 and
SOCS-1 (Fig. 7N and O). Of note, it was recently demonstrated
that WNT5A-mediated, calcium-activated calmodulin kinase
(Ca2/CAMKII), with several signaling intermediates, plays a cru-
cial role in immune cell functions (33–35). Therefore, we investi-
gated the involvement of the WNT5A-Ca2/CAMKII axis in
the dectin-1-mediated signaling pathway. The WNT5A-Ca2/
CAMKII pathway is subsequently known to drive NF-B-medi-
ated gene expression through TGF--activated kinase (TAK1)
FIG 5 Dectin-1 activates Syk and produces ROS to induce the expression of PIAS-1 and SOCS-1. (A and B) Immunoblot analysis of pSyk (A) and detection of
ROS by DCFDA (B) in mouse peritoneal macrophages treated with curdlan at the indicated time points. , no curdlan treatment. (C and D) RAW 264.7
macrophages are transiently transfected with Dectin-1 siRNA followed by treatment with curdlan for 60 min. Immunoblotting analysis of pSyk in whole-cell
lysates (C) and ROS production (D) was analyzed by DCFDA. (E) Mouse peritoneal macrophages were pretreated with Syk inhibitor for 60 min and then treated
with curdlan for 12 h. Total cell lysates were analyzed for PIAS-1 and SOCS-1 by immunoblotting. (F) ROS detection in macrophages from WT or TLR2/mice
which are treated with curdlan for 120 min. (G) Peritoneal macrophages isolated from C57BL/6J WT and NCF1/ mice were treated with curdlan for 12 h.
Lysates were analyzed for PIAS-1 and SOCS-1 by immunoblotting. (H) C57BL/6J WT or NCF1/ mice were intravenously challenged with curdlan for 12 h.
Spleen and lymph nodes were isolated and analyzed for PIAS1 and SOCS-1 expression by quantitative real-time RT-PCR. All blots are representative of 3
independent experiments, and all data represent the means	 SEM from 3 independent experiments. *, P
 0.05; **, P
 0.005; ***, P
 0.001; Med, medium;
WT, wild type; NCF1/, p47phox/ (mice deficient in ROS production).
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and proline-rich tyrosine kinase (Pyk2) (36, 37). Dectin-1-in-
duced expression of WNT5A led to the activation of CAMKII,
TAK1, and Pyk2, which was further validated by genetic knock-
down of WNT5A by specific siRNA (Fig. 8A and B). Inhibition of
TAK1, either by the kinase-negative mutant construct (Fig. 8C) or
siRNA (Fig. 8D and E), and pharmacological intervention of ac-
tivity of CAMKII and Pyk2 (Fig. 8F) implicated the involvement
of WNT5A-Ca2/CAMKII-Pyk2 and the TAK1 axis in dectin-1-
induced expression of PIAS-1 and SOCS-1. Next, we demon-
strated that there is increased nuclear translocation of NF-B in
macrophages upon engagement of dectin-1 receptor with curdlan
(Fig. 8G) via the WNT-Ca2/CAMKII-TAK1 axis. Pharmacolog-
ical intervention of NF-B translocation by BAY 11-7082 further
implicated the role for NF-B in dectin-1-induced expression of
PIAS-1 and SOCS-1 (Fig. 8G and H). All together, we demon-
strated that dectin-1-induced expression of PIAS-1 and SOCS-1
required ROS-stabilized -catenin and WNT5A production.
The Syk-ROS-WNT-Ca2/CAMKII axis effectuates dectin-
1-induceddownregulationof IRAK-1, IRAK-4, andMyD88.The
WNT5A-Ca2/CAMKII axis regulated nuclear translocation of
NF-B and induced the expression of PIAS-1 and SOCS-1. The
contribution of such a signaling axis in dectin-1-mediated impair-
ment of TLR functions by degrading IRAK-1, IRAK-4, and
MyD88 was validated. Experiments utilizing a pharmacological
inhibitor of ROS or macrophages from NCF1-null mice clearly
implicated the need for ROS in fungus- or curdlan-induced deg-
radation of IRAK-1, IRAK-4, and MyD88 (Fig. 9A to C). Further,
signaling perturbation studies by pharmacological agents or ge-
FIG 6 SyK-ROS-stabilized -catenin mediates dectin-1 ligand-induced expression of PIAS-1 and SOCS-1. (A) Immunoblotting analysis of p-catenin and
pGSK-3 in whole-cell lysates of mouse macrophages pretreated with Syk inhibitor or DPI for 60 min followed by treatment with curdlan. (B) Expression analysis
of PIAS-1 and SOCS-1 by immunoblotting in RAW 264.7 macrophages transiently transfected with the indicated OE constructs followed by treatment with
curdlan for 12 h. (C) Immunopulldown (IP) with anti-Flag antibody followed by immunoblot analysis for Myc in RAW 264.7 macrophages transiently
transfected with respective constructs in the presence or absence of SyK inhibitor or DPI. (D) Mouse peritoneal macrophages were pretreated with -catenin
inhibitor for 60 min or with LiCl alone for 4 h and then treated with curdlan for 12 h. Expression of PIAS-1 and SOCS-1 was analyzed by immunoblotting. (E)
RAW 264.7 macrophages were transiently transfected with -catenin OE followed by treatment with curdlan. Total cell lysates were analyzed for PIAS-1 and
SOCS-1 by immunoblotting. (F) Validation of-catenin OE construct. (G and H) Peritoneal macrophages from C3H/HeJ mice were transiently transfected with
-catenin siRNA followed by treatment with curdlan for 12 h. Lysates were analyzed for PIAS-1 and SOCS-1 expression (G) and -catenin levels (H) by
immunoblotting. (I and J) Mouse peritoneal macrophages from C3H/HeJ mice were infected with the indicated fungi and bacteria (I) or coinfected with C.
albicans followed by the tested bacteria (J) for 60 min to assess p-catenin and pGSK-3 levels and for 12 h to assess PIAS-1 and SOCS-1. All blots are
representative of 3 independent experiments. WT, wild type; MT, mutant; NT, nontargeting; IB, immunoblot; OE, overexpression construct.
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netic knockdown procedures implicated the role for Syk (Fig. 9D),
-catenin (Fig. 9E to G), and WNT5A (Fig. 9H to J). Concordant
results were obtained to demonstrate that Ca2/CAMKII-Pyk2
(Fig. 9K), TAK1 (Fig. 9L and M), and NF-B (Fig. 9N) played
significant roles in dectin-1-induced degradation of IRAK-1,
IRAK-4, and MyD88.
DISCUSSION
PRRs play a vital role in sensing the existing as well as the invading
microbes to elicit protective immune responses (38). However, the
cross-regulation among PRRs and the outcome of such cross talk
during pathogenic infections is not dealt with in detail. In the present
study, we identify a novel role for a developmental pathway such as
the WNT signaling pathway in dictating such cross-regulations of
PRR signaling in macrophages. Generally, activation of multiple
PRRs takes place during infection in a cell due to the presence of
complex cell wall components which serve as ligands for numerous
PRRs (39). In the present context, we looked at the activation of dec-
tin-1 receptor, a CLR family of PRR in macrophages. Though several
reports implicate the necessary role for TLR2 in the execution of dec-
tin-1-mediated gene expression (16), we report a TLR2-independent
dectin-1 signaling axis. In order to address the signaling cascades in-
volved in immune responses mediated by the dectin-1 pathway, we
have utilized fungi, such asC. albicans,A. flavus, andA. fumigatusor
a commercially available ligand, curdlan. Curdlan is a well-known
selective dectin-1 agonist which is purified macroparticulate-(1,
3)glucan from Alcaligenes faecalis (26, 40).
Activation of TLR and dectin-1 significantly abrogated the
FIG 7 -Catenin-mediated dectin-1-induced PIAS-1 and SOCS-1 expression requires WNT5A signaling. (A) Quantitative real-time RT-PCR analysis of WNT
ligands in macrophages treated with curdlan for 12 h. (B) Peritoneal macrophages from C3H/HeJ mice were infected with the indicated fungi to estimate the
expression of WNT5A by immunoblotting. (C) RAW 264.7 macrophages were transfected with WNT5A OE construct followed by pretreatment with -catenin
inhibitor. Cells were treated with curdlan for 12 h and then analyzed for PIAS-1 and SOCS-1 expression by immunoblotting. (D) RAW 264.7 macrophages were
transfected with the dectin-1 MT construct and treated with curdlan for 4 h to analyze WNT5A expression by immunoblotting. (E) Immunoblotting analysis of
WNT5A in peritoneal macrophages from C3H/HeJ mice transfected with Dectin-1 siRNA. (F) C57BL/6J WT or NCF1/mice were intravenously injected with
curdlan for 18 h. Spleen and lymph nodes were isolated and analyzed for Wnt5a expression by quantitative real-time RT-PCR. (G) Immunoblotting analysis for
WNT5A in macrophages from C57BL/6J WT or NCF1/mice treated with curdlan for 4 h. Macrophages were treated with-catenin inhibitor or with LiCl (H)
or transfected with the -catenin OE construct (I) and then treated with curdlan for 4 h. Whole-cell lysates were analyzed for WNT5A expression by immuno-
blotting. (J) Immunoblotting analysis of WNT5A in peritoneal macrophages from C3H/HeJ mice transfected with -catenin siRNA followed by treatment with
curdlan for 4 h. (K to M) RAW 264.7 macrophages transfected with TCF4 DN (K) or WNT5A OE (L and M) were treated with curdlan for 12 h. Total cell lysates
were analyzed for PIAS-1, SOCS-1 (K and L), and WNT5A (K and M) by immunoblotting. Immunoblotting analysis for PIAS-1, SOCS-1 (N), and WNT5A (O)
in peritoneal macrophages from C3H/HeJ mice transfected with Wnt5a siRNA followed by treatment with curdlan. All blots are representative of 3 independent
experiments, and all data represent the means	 SEM from 3 independent experiments. **, P
 0.005. Med, medium; MT, mutant; NT, nontargeting; WT, wild
type; NCF1/, p47phox/ (mice deficient in ROS production); OE, overexpression construct; DN, dominant negative.
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TLR-induced expression of inflammatory genes like those encod-
ing TNF-, IL-12, and IL-1. Later on, we also demonstrated that
the inhibitory role of dectin-1 over the TLR pathway is brought
about by two negative modulators of cytokine as well as TLR sig-
naling, namely, PIAS-1 and SOCS-1, in macrophages. Notably, to
show the correlation of this study with the in vivo infection sce-
nario, we analyzed the bacterial load in the curdlan-treated mice.
Triggering of dectin-1 prior to TLR by curdlan significantly in-
creased the bacterial CFU not only in macrophages in vitro but
also in lymph node and spleen in vivo. These results underscore
one of the possible pathogen-mediated evasion strategies to
dampen the host immune responses.
Activation of host signaling pathways upon engagement of sur-
face- or intracellular-expressed PRRs is shown to dictate the im-
mune cell fate. Contribution of signaling pathways like Sonic
Hedgehog (30), WNT (31), and NOTCH (41, 42) has been deci-
phered during various bacterial infections as well as during de-
railed inflammation (43–45). Here, we found significant contri-
bution of WNT5A during dectin-1-mediated immune responses.
WNT5A executes its function through FZD, a seven-pass trans-
membrane protein which functions similar to G-protein-coupled
receptors (32). Interaction of WNT5A-FZD results in the activa-
tion of membrane-bound phospholipase, which eventually leads
to release of intracellular Ca2 (36). This in turn activates CAMKII
and subsequently drives NF-B-mediated gene expression through
TAK1 and Pyk2 (35). In line with these observations, dectin-1-in-
duced expression of WNT5A led to the activation of the Ca2/CAM-
KII pathway and in turn regulated the expression of PIAS-1 and
SOCS-1. TAK1 and Pyk2 are known regulators of B-cell receptor
(BCR)-mediated B cell functions (46) and macrophage function
(47). Our data clearly suggest the involvement of crucial kinases, like
TAK1 and Pyk2, in mediating dectin-1-induced WNT5A-Ca2/
CAMKII signaling. NF-B, a unique transcription factor, is shown to
regulate numerous immune cell functions under various pathologi-
cal conditions (42, 48). Regulation of NF-B nuclear translocation by
TAK1 has been reported in T-cell-mediated functions (49). We
found that TAK1–NF-B signaling regulated dectin-1-induced
PIAS-1 and SOCS-1 expression.
As described earlier in several published reports, targeting the
adaptor molecules of the TLR signaling pathway is one of the
FIG8 WNT5A-Ca2/CAMKII signaling axis regulates dectin-1-induced PIAS-1 and SOCS-1 expression. (A) Immunoblotting analysis for pCAMKII, Pyk2, and
pTAK1 in macrophages treated with curdlan for the indicated time intervals. (B) Total cell lysates from peritoneal macrophages transfected with Wnt5a siRNA
and treated with curdlan were analyzed for pCAMKII, pPyk2, and pTAK1 levels. (C to E) RAW 264.7 macrophages transfected with the TAK1 KN construct (C)
orTak1 siRNA (D and E) were treated with curdlan for 12 h. Total cell lysates were analyzed for PIAS-1 and SOCS-1 (C and D) and TAK1 (E) by immunoblotting.
Mouse peritoneal macrophages from C3H/HeJ mice were pretreated with the indicated pharmacological inhibitors followed by 12 h (F) or 60 min (G) of
treatment with curdlan to estimate the expression of PIAS-1 and SOCS-1 from whole-cell lysate (F) or nuclear translocation of NF-B from nuclear and cytosolic
fractions (G). (H) Analysis of curdlan-induced PIAS-1 and SOCS-1 expression in macrophages pretreated with NF-B inhibitor, BAY 11-7082. All blots are
representative of 3 independent experiments. NT, nontargeting; KN, kinase negative.
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mechanisms involved in regulating TLR-mediated inflammatory
gene expression (50). It has been shown that MyD88, one of the
adaptor molecules associated with TLR signaling pathways, is tar-
geted to proteosomal degradation by E3 ligases like Smurf (24).
On the other hand, tripartite motif-containing (TRIM) proteins,
another component of innate immune cell signaling pathways, are
driven for proteosomal degradation by E3 ligases. Interestingly,
though microRNA-mediated downregulation of TLR adaptors
has been previously reported (43), no studies indicate roles for
other posttranslational modifications to regulate their levels and
subsequently inhibit TLR responses. In the present context, we
observed the role for PIAS-1 and SOCS-1 in downregulating
IRAK-1, IRAK-4, and MyD88 in macrophages in response to dec-
tin-1 signaling. Interestingly, we found SOCS-1 mediated the dec-
tin-1-responsive IRAK-1, IRAK-4, and MyD88 proteasomal deg-
radation, and PIAS-1 action was limited to IRAK-1 and MyD88
degradation. These results emphasize the substrate specificity of
E3-modifying enzymes like PIAS-1 and SOCS-1 in regulating the
strength of innate immune responses upon activation of PRRs,
such as TLRs. The SOCS family of genes is known to bring about
ubiquitination-mediated degradation of target proteins such as
STAT, thus downregulating IFN- response (51, 52). The PIAS
family of proteins sumoylate several known immune modulators,
thus relegating them to a new cellular location and resulting in a
loss of function (53–55).
Our study suggests that activation of dectin-1 and TLR path-
ways in an infected cell by invading pathogens or during coinfec-
tions might bring down the inflammatory responses. All together,
these results suggest that dectin-1-induced degradation of
IRAK-1, IRAK-4, and MyD88 is mediated through PIAS-1 and
FIG 9 Syk-ROS-WNT-Ca2/CAMKII pathway mediates dectin-1-induced degradation of IRAK-1, IRAK-4, and MyD88. Immunoblotting analysis for IRAK-1,
IRAK-4, and MyD88 in total cell lysates of peritoneal macrophages pretreated with DPI followed by 12 h curdlan treatment (A), peritoneal macrophages from
C57BL/6J WT or NCF1/ mice treated with respective fungi at an MOI of 1:10 for 12 h (B), peritoneal macrophages from C57BL/6J WT or NCF1/ mice
treated with curdlan for 12 h (C), peritoneal macrophages from C3H/HeJ mice pretreated with Syk inhibitor (D) or -catenin inhibitor or LiCl (E) followed by
treatment with curdlan for 12 h, RAW 264.7 macrophages transfected with -catenin OE construct followed by 12 h of curdlan treatment (F), peritoneal
macrophages from C3H/HeJ mice transfected with -catenin siRNA followed by 12 h of curdlan treatment (G), peritoneal macrophages from C3H/HeJ mice
pretreated with the indicated pharmacological inhibitors for 60 min followed by curdlan treatment for 12 h (H), RAW 264.7 macrophages (I) or peritoneal
macrophages from C3H/HeJ mice (J) transiently transfected with the WNT5A OE construct (I) or Wnt5a siRNA (J) followed by treatment with curdlan for 12
h, peritoneal macrophages pretreated with the indicated pharmacological inhibitors followed by 12 h of curdlan treatment (K), RAW 264.7 macrophages
transfected with the TAK1 KN construct (L) or Tak1 siRNA followed by 12 h of curdlan treatment (M) and peritoneal macrophages from C3H/HeJ mice
pretreated with BAY 11-7082 followed by treatment of curdlan for 12 h (N). All blots are representative of 3 independent experiments. Med, medium; WT, wild
type; NCF1/, p47phox/ (mice deficient in ROS production); OE, overexpression construct; NT, nontargeting; KN, kinase negative.
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SOCS-1 that require WNT5A-activated Ca2/CAMKII–NF-B
activity (Fig. 10).
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